Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
Mohan
Aparna K
AK
Edwards
Evelyne T
ET
Coté
Timothy R
TR
Siegel
Jeffrey N
JN
Braun
M Miles
MM
D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000494:pharmacology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept